<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0043">
 <label>43</label>
 <mixed-citation publication-type="journal" id="CIT0043-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Supuran</surname>
    <given-names>CT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dinculescu</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Balaban</surname>
    <given-names>AT.</given-names>
   </name>
  </person-group>
  <article-title>Carbonic anhydrase activators. Part 5. CA II activation by 2,4,6-trisubstituted pyridinium cations with 1-(ω-aminoalkyl) side chains</article-title>. 
  <source>Rev Roum Chim</source>
  <year>1993</year>;
  <volume>38</volume>:
  <fpage>343</fpage>–
  <lpage>9</lpage>.
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0043-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Pastorekova</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Casini</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Scozzafava</surname>
    <given-names>A</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX</article-title>. 
  <source>Bioorg Med Chem Lett</source>
  <year>2004</year>;
  <volume>14</volume>:
  <fpage>869</fpage>–
  <lpage>73</lpage>.
  <pub-id pub-id-type="pmid">15012984</pub-id>
 </mixed-citation>
</ref>
